BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Mundipharma International Limited 

Unit 220
Cambridge Science Park
Milton Road

Cambridge    CB4 0GW  England
Phone: 44-1223-424211 Fax: 44-1223-426626


SEARCH JOBS




Industry
Pharmaceutical






 Company News
flutiform® Launched In Spain; Abriff® Launched In Italy SkyePharma Inc. (SKYE) To Receive €2 Million Milestone From Mundipharma International Limited 12/1/2014 2:39:05 PM
Mundipharma International Limited's Commitment to Accelerated Business Growth Supported by Appointment of Paul Medeiros to Head its Corporate and Business Development 3/14/2012 6:45:44 AM
Horizon Pharma, Inc. Enters Into Exclusive Agreement With Mundipharma International Limited for Commercialization of LODOTRA(R) (Modified-Release Prednisone) in Latin America 3/7/2012 8:49:50 AM
Infinity Pharmaceuticals Inc. (INFI) Gets $50 Million More in Mundipharma International Limited Deal 11/29/2011 7:02:20 AM
Mundipharma International Limited Release: New Research Shows Chronic Pain is not Being Adequately Measured[1] 10/10/2011 11:35:28 AM
Infinity Pharmaceuticals Inc. (INFI) and Mundipharma International Limited Extend Global Strategic Alliance; Mundipharma Commits to Providing Up to $110 Million for 2012 12/13/2010 11:55:40 AM
Infinity Pharmaceuticals Inc. (INFI) Announces That Purdue Pharmaceutical Products L.P. and Mundipharma International Limited Exercise Rights to Develop and Commercialize Infinity's FAAH Pain Program Worldwide 10/26/2010 8:56:25 AM
Mundipharma International Limited: Levact(R) (bendamustine) Recommended for Approval in Europe for Treating Blood Cancers 3/19/2010 10:44:57 AM
Novelos Therapeutics, Inc. and Mundipharma International Limited Sign Exclusive Collaboration Agreement in Europe and Japan; Deal Potentially Worth $95 Million 2/12/2009 7:43:11 AM
Infinity Pharmaceuticals, Inc. Announces Global Strategic Alliance With Purdue Pharmaceuticals L.P. and Mundipharma International Limited Encompassing Infinity's Early Clinical and Discovery Programs; Infinity to Receive Up to $75M Equity Investment, Access to $50M Line of Credit, and Significant R&D Funding Over Multiple Years 11/20/2008 8:50:59 AM
12